| Peter Nagi, | |
|
1717 6th Ave S, Birmingham, AL 35233-1801 | |
| (800) 822-8816 | |
| Not Available |
| Full Name | Peter Nagi |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 25 Years |
| Location | 1717 6th Ave S, Birmingham, Alabama |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124079058 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 23678 (Alabama) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Alabama Hospital | Birmingham, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Alabama Health Services Foundation, Pc | 1951213107 | 2344 |
News Archive
Basis, a company offering an innovative approach to taking care of your mental health, announced today the launch of its new service designed to bring evidence-based support to more people.
Dr. Levy pioneered a procedure known as supraorbital nerve stimulation or SOS, in which neurotransmitters are implanted into the forehead to block head pain. Tiny wires are burrowed under the skin until the precise location of pain is marked by a tingling response to electrical charge. The wires are kept in place for a week, and if pain is lessened and the patient is comfortable with the technology, neurotransmitters are surgically implanted under local anesthesia. The patient is able to control pain relief by manually adjusting the level of electrical stimulation through a hand held device.
Researchers at the Smidt Heart Institute at Cedars-Sinai discovered that a non-treatable form of lethal heart rhythm responsible for sudden cardiac arrest is twice as likely to be found in patients with the most common form of heart failure-heart failure with preserved ejection fraction (HFpEF), compared to heart failure with reduced ejection fraction (HFrEF).
A new study by researchers at The George Institute for International Health has found that back pain is a reoccurring problem for five million Australians.
An increased dosage of Tamiflu (oseltamivir) for patients with critical illness is unlikely to be required in the treatment of pandemic (H1N1) influenza, contrary to current international guidelines, found a new study http://www.cmaj.ca/cgi/doi/10.1503/cmaj.092127 in CMAJ (Canadian Medical Association Journal) www.cmaj.ca.
› Verified 3 days ago
| Entity Name | University Of Alabama Health Services Foundation, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093768723 PECOS PAC ID: 1951213107 Enrollment ID: O20031105000261 |
News Archive
Basis, a company offering an innovative approach to taking care of your mental health, announced today the launch of its new service designed to bring evidence-based support to more people.
Dr. Levy pioneered a procedure known as supraorbital nerve stimulation or SOS, in which neurotransmitters are implanted into the forehead to block head pain. Tiny wires are burrowed under the skin until the precise location of pain is marked by a tingling response to electrical charge. The wires are kept in place for a week, and if pain is lessened and the patient is comfortable with the technology, neurotransmitters are surgically implanted under local anesthesia. The patient is able to control pain relief by manually adjusting the level of electrical stimulation through a hand held device.
Researchers at the Smidt Heart Institute at Cedars-Sinai discovered that a non-treatable form of lethal heart rhythm responsible for sudden cardiac arrest is twice as likely to be found in patients with the most common form of heart failure-heart failure with preserved ejection fraction (HFpEF), compared to heart failure with reduced ejection fraction (HFrEF).
A new study by researchers at The George Institute for International Health has found that back pain is a reoccurring problem for five million Australians.
An increased dosage of Tamiflu (oseltamivir) for patients with critical illness is unlikely to be required in the treatment of pandemic (H1N1) influenza, contrary to current international guidelines, found a new study http://www.cmaj.ca/cgi/doi/10.1503/cmaj.092127 in CMAJ (Canadian Medical Association Journal) www.cmaj.ca.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Peter Nagi, 1717 6th Ave S, Birmingham, AL 35233-1801 Ph: () - | Peter Nagi, 1717 6th Ave S, Birmingham, AL 35233-1801 Ph: (800) 822-8816 |
News Archive
Basis, a company offering an innovative approach to taking care of your mental health, announced today the launch of its new service designed to bring evidence-based support to more people.
Dr. Levy pioneered a procedure known as supraorbital nerve stimulation or SOS, in which neurotransmitters are implanted into the forehead to block head pain. Tiny wires are burrowed under the skin until the precise location of pain is marked by a tingling response to electrical charge. The wires are kept in place for a week, and if pain is lessened and the patient is comfortable with the technology, neurotransmitters are surgically implanted under local anesthesia. The patient is able to control pain relief by manually adjusting the level of electrical stimulation through a hand held device.
Researchers at the Smidt Heart Institute at Cedars-Sinai discovered that a non-treatable form of lethal heart rhythm responsible for sudden cardiac arrest is twice as likely to be found in patients with the most common form of heart failure-heart failure with preserved ejection fraction (HFpEF), compared to heart failure with reduced ejection fraction (HFrEF).
A new study by researchers at The George Institute for International Health has found that back pain is a reoccurring problem for five million Australians.
An increased dosage of Tamiflu (oseltamivir) for patients with critical illness is unlikely to be required in the treatment of pandemic (H1N1) influenza, contrary to current international guidelines, found a new study http://www.cmaj.ca/cgi/doi/10.1503/cmaj.092127 in CMAJ (Canadian Medical Association Journal) www.cmaj.ca.
› Verified 3 days ago
Riaz Mohammed Karukappadath, Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 619 19th St S, Birmingham, AL 35249 Phone: 205-934-4011 | |
Dr. Victor E. Mendoza, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 5130 Cyrus Cir, Birmingham, AL 35242 Phone: 205-981-0414 | |
Joshua Edward Smith, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 619 19th Street South, Birmingham, AL 35233 Phone: 205-934-6600 | |
Stacy Wade, Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1717 6th Ave S, Birmingham, AL 35233 Phone: 800-822-8816 | |
Bernis A Simmons, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 52 Medical Park Dr E, Suite 321, Birmingham, AL 35235 Phone: 205-838-3055 Fax: 205-838-3517 | |
George R. Wells Iii, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1201 11th Ave S, Birmingham, AL 35205 Phone: 205-930-7246 | |
Teddy W. Sartin, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 1600 Carraway Blvd, Birmingham, AL 35234 Phone: 205-502-6817 Fax: 205-502-5152 |